000 01754 a2200505 4500
005 20250515000419.0
264 0 _c20060414
008 200604s 0 0 eng d
022 _a0920-9964
024 7 _a10.1016/j.schres.2005.07.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeyer, Jonathan M
245 0 0 _aThe Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.
_h[electronic resource]
260 _bSchizophrenia research
_cDec 2005
300 _a9-18 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAdult
650 0 4 _aAnthropometry
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBlood Glucose
650 0 4 _aBlood Pressure
650 0 4 _aBody Mass Index
650 0 4 _aCholesterol, HDL
_xblood
650 0 4 _aFasting
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xtherapeutic use
650 0 4 _aInsulin
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMetabolic Syndrome
_xblood
650 0 4 _aPrevalence
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aTriglycerides
_xblood
700 1 _aNasrallah, Henry A
700 1 _aMcEvoy, Joseph P
700 1 _aGoff, Donald C
700 1 _aDavis, Sonia M
700 1 _aChakos, Miranda
700 1 _aPatel, Jayendra K
700 1 _aKeefe, Richard S E
700 1 _aStroup, T Scott
700 1 _aLieberman, Jeffrey A
773 0 _tSchizophrenia research
_gvol. 80
_gno. 1
_gp. 9-18
856 4 0 _uhttps://doi.org/10.1016/j.schres.2005.07.015
_zAvailable from publisher's website
999 _c15761931
_d15761931